Expenses relating to the youtheory acquisition and integration. Forms and Publications | Kaiser Permanente Gross profit margin to remain consistent with the prior year as the expected decline in Jamieson Brands margins is offset by favourable customer and program mix impacting Strategic Partners. Mr. Williams retirement from the Board will take effect upon conclusion of the AGM. 1710 Hamilton Avenue, Suite 4. Gross profit increased 44.1% to $71.2 million in the fourth quarter of 2022. Jamieson Wellness Inc. Announces Date of Second Quarter 2023 Financial The Company uses the following non-IFRS financial measures: EBITDA, Adjusted EBITDA and Adjusted net earnings, the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, normalized gross profit, normalized SG&A, normalized earnings from operations, cash from operating activities before working capital considerations and net debt, the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: Adjusted EBITDA margin, Adjusted diluted earnings per share, normalized gross profit margin, normalized operating margin, and the following supplementary financial measures: gross profit margin and operating margin to provide supplemental measures of the Companys operating performance and thus highlight trends in the Companys core business that may not otherwise be apparent when relying solely on IFRS financial measures. We have audited the consolidated financial statements of Jamieson Wellness Inc. and its subsidiaries (the Group), which comprise the consolidated statements of financial position as at December 31, 2021 and 2020, the consolidated . Jamieson Wellness Full year 2021 includes a one-time impact of $0.9 million in the first quarter of 2021 relating to the acceleration of share-based compensation expense from future years in relation to the Companys CEO transition. See the Non-IFRS and Other Financial Measures section of this press release for more information on each supplementary financial measure. The Companys audited consolidated annual financial statements and accompanying notes as at and for the three and twelve months ended December 31, 2022 and related MD&A are available under the Companys profile on SEDAR at www.sedar.com and on the Investor Relations section of the Companys website at https://investors.jamiesonwellness.com. Expenses in the fourth quarter of 2021 relate to system implementation costs while full year 2021 expenses mostly relate to start-up costs to complete the Companys transition to a third-party logistics model to make room for capacity expansion at its Twin Oaks and Scarborough distribution facilities. All amounts are expressed in Canadian dollars. This information reflects the Companys current expectations regarding future events. The passcode for the replay is 1883631 and it will be available until Thursday March 9, 2023. We will continue to build our world-class brands by leveraging our best-in-class marketing, innovation and omni channel distribution capabilities to drive significant global expansion of our high-quality products and enhance value for all stakeholders., Fourth Quarter 2022 versus Fourth Quarter 2021 Results. The board of directors of the Company authorized and declared a cash dividend for the fourth quarter of 2022 of $0.17 per common share, or approximately $7.1 million in the aggregate. Management also uses nonIFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. Earnings from operations increased by $6.1 million, or 27.0%, to $28.9 million in the fourth quarter of 2021 and operating margin(3) increased by 3.3% to 22.2% as a result of higher revenue and gross profit margins, along with lower fixed costs as a percentage of revenue. A quantitative reconciliation of reported net earnings to EBITDA, Adjusted EBITDA, and non-IFRS normalized gross profit, normalized SG&A, normalized earnings from operations and Adjusted net earnings are included in the table accompanying this release under the heading Non-IFRS and Other Financial Measures. Jamieson Wellness Inc. Reports First Quarter 2019 Financial Results and Words such as expect, anticipate, intend, may, will, estimate and variations of such words and similar expressions are intended to identify such forward-looking information. PDF Unaudited Condensed Consolidated Interim Financial Statements For the In July, we closed on our acquisition of the youtheory brand, providing us with a strong platform and premium brand offering in the United States. The call can be accessed live over the telephone by dialing 1-888-204-4368 from Canada and the U.S. or 1-323-994-2093 from international locations. Q3 '21. Jamieson Wellness is dedicated to improving the world's health and wellness with its portfolio of innovative natural health brands. Prior year expenses included start-up costs of $1.5 million in the aforementioned third-party logistics transition. This information is based on the Companys reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Companys cash as at December 31, 2021 was $6.8 million compared with $1.2 million on December 31, 2020. Key facts Market capitalization Dividends yield (FY) Price to earnings Ratio (TTM) Basic EPS (TTM) Founded Employees CEO Website Valuation Fundamental metrics to determine fair value of the stock Summary P/E ratio P/S ratio Market Cap Net income Revenue Valuation ratios Growth and Profitability The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. Data may be intentionally delayed pursuant to supplier requirements. Jamieson Wellness Inc. Reports Second Quarter 2018 Financial Results Normalized earnings from operations(1) increased by $4.2 million, or 16.7% in the fourth quarter of 2021 and normalized operating margin(2) was 22.4% compared with 20.7% in the fourth quarter of 2020. The Companys domestic branded sales increased by 8.9% in the first quarter of 2022, reflecting strong point of purchase sales, timing of sales to support seasonal promotional activities, and pricing. (1) This is a non-IFRS financial measure. All amounts are expressed in Canadian dollars. Established in 1922, Jamieson is the Company's heritage brand and Canada's #1 consumer health brand. DirectorJamieson Wellness Inc. Unaudited Consolidated Interim Statements of Operations and Comprehensive Income In thousands of Canadian dollars, except share and per share amounts Notes Three months ended March 31,20232022 The Companys international USD denominated revenue(3) increased by 12.4% on a constant currency basis, or 13.5% on a reported basis compared with the first quarter of 2021 led by continued growth in China while overlapping significant growth from strong non-immunity shipments during the same period in the prior year. PDF Unaudited Condensed Consolidated Interim Financial Statements For the This outlook reflects the following assumptions: (1) This is a non-IFRS financial measure. San Jose, CA 95125. Ruth Winker The partnership will leverage the combined expertise of both companies and is expected to accelerate Jamieson Wellness' strong organic growth in China. Management will host a conference call to discuss the Companys first quarter 2022 results at 5:00 p.m. Full year 2021 excludes PSUs and RSUs granted to certain employees, and the acceleration of $0.9 million of share-based compensation expense from future years in relation to the Companys CEO transition, net of $1.0 million in tax benefits realized on the vesting of certain share-based awards. Reconciliation of Non-IFRS Financial Measures Cash invested in working capital decreased by $13.3 million driven by favourable timing on the collection of receivables and accelerated inventory purchases realized in previous quarters. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the second quarter 2023 results. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the How we Assess the Performance of our Business section of the MD&A, which is incorporated by reference. TORONTO-- (BUSINESS WIRE)-- Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX: JWEL) today reported financial results for its fourth quarter and twelve months ended December 31, 2018. Quarterly Results - Jamieson Wellness Interested parties may listen to a simultaneous webcast of the conference call by logging on via the Investor Relations section of the Company's website at https://investors.jamiesonwellness.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1594444&tp_key=5d1e64a28e. Find care. 2021-11-04 | TSX:JWEL | Press Release | Jamieson Wellness - Stockhouse These major strategic actions defined our centennial year and have placed us in a strong position for growth as we enter our next century of helping consumers around the world optimize their health and wellness. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority. Selling, general and administrative (SG&A) expenses increased by $13.2 million to $32.8 million in the fourth quarter of 2022. The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations, each of which are non-IFRS financial measures (see the Non-IFRS and Other Financial Measures of this press release for further information on each non-IFRS financial measure) for the three months ended March 31, 2022 and March 31, 2021.